Tobacco Products: FDA Regulation and Use of Fees

Jared Hart (Editor)

Series: Government Procedures and Operations
BISAC: LAW075000

Clear

$69.00

Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick

eBook

Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:

Quantity:

Details

Tobacco use is the leading cause of preventable death and disease in the United States. In 2009, the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) granted FDA, an agency within the Department of Health and Human Services (HHS), authority to regulate tobacco products, including marketing and distribution to youth.

The act established CTP, which implements the act by educating the public on the dangers of tobacco use; developing the science needed for tobacco regulation; and developing and enforcing regulations on the manufacture, marketing, and distribution of tobacco products. The act authorized FDA to assess and collect user fees from tobacco manufacturers and importers. This book examines how FDA spent tobacco user fees for key activities using its authorities granted in the act, and any challenges FDA encountered in using its authorities.
(Imprint: Novinka)

Preface

Chapter 1 - Tobacco Product Regulation: Most FDA Spending Funded Public Education, Regulatory Science, and Compliance and Enforcement Activities (pp. 1-52)
United States Government Accountability Office

Chapter 2 - FDA Final Rule Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco (pp. 53-74)
C. Stephen Redhead and Jane M. Smith

Index

You have not viewed any product yet.